Cargando…

Histopathological grading of pediatric ependymoma: reproducibility and clinical relevance in European trial cohorts

BACKGROUND: Histopathological grading of ependymoma has been controversial with respect to its reproducibility and clinical significance. In a 3-phase study, we reviewed the pathology of 229 intracranial ependymomas from European trial cohorts of infants (2 trials - SFOP/CNS9204) and older children...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ellison, David W, Kocak, Mehmet, Figarella-Branger, Dominique, Felice, Giangaspero, Catherine, Godfraind, Pietsch, Torsten, Frappaz, Didier, Massimino, Maura, Grill, Jacques, Boyett, James M, Grundy, Richard G
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2011
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3117833/ https://www.ncbi.nlm.nih.gov/pubmed/21627842 http://dx.doi.org/10.1186/1477-5751-10-7

Ejemplares similares

Integrating Tenascin-C protein expression and 1q25 copy number status in pediatric intracranial ependymoma prognostication: A new model for risk stratification
por: Andreiuolo, Felipe, et al.
Publicado: (2017)

Trisomy 19 ependymoma, a newly recognized genetico-histological association, including clear cell ependymoma
por: Rousseau, Emmanuel, et al.
Publicado: (2007)

Toward Improved Diagnosis Accuracy and Treatment of Children, Adolescents, and Young Adults With Ependymoma: The International SIOP Ependymoma II Protocol
por: Leblond, Pierre, et al.
Publicado: (2022)

EPEN-24. Biological markers of ependymoma in children and adolescents (BIOMECA): Systematic comparison of methods for the precise evaluation of biomarkers for ependymoma diagnosis and prognostication
por: Chapman, Rebecca, et al.
Publicado: (2022)

Optimizing biomarkers for accurate ependymoma diagnosis, prognostication, and stratification within International Clinical Trials: A BIOMECA study
por: Chapman, Rebecca J, et al.
Publicado: (2023)

EPEN-02. OPTIMISING BIOMARKERS FOR ACCURATE EPENDYMOMA DIAGNOSIS, PROGNOSTICATION AND STRATIFICATION WITHIN INTERNATIONAL CLINICAL TRIALS: A BIOMECA STUDY
por: Chapman, Rebecca J, et al.
Publicado: (2023)

WHO grade has no prognostic value in the pediatric high-grade glioma included in the HERBY trial
por: Varlet, Pascale, et al.
Publicado: (2020)

The current consensus on the clinical management of intracranial ependymoma and its distinct molecular variants
por: Pajtler, Kristian W., et al.
Publicado: (2016)

MEDB-68. Analysis of telomeres length and Alternative Lengthening of Telomeres (ALT) in molecular subgroups of infant medulloblastoma
por: Buttarelli, Francesca Romana, et al.
Publicado: (2022)

Diagnostics of pediatric supratentorial RELA ependymomas: integration of information from histopathology, genetics, DNA methylation and imaging
por: Pagès, Mélanie, et al.
Publicado: (2018)

Pediatric ependymoma: an overview of a complex disease
por: Jünger, Stephanie Theresa, et al.
Publicado: (2021)

MEDB-35. Relationship between genetic profile, histology, clinical features and long-term outcome in young children medulloblastoma (YCMB) treated with upfront high dose chemotherapy (HDCT) in Italy
por: Garrè, Maria Luisa, et al.
Publicado: (2022)

Pediatric ependymomas: destined to recur?
por: Ritzmann, Timothy A, et al.
Publicado: (2021)

Chondro-Osseous Metaplasia in Ependymoma: A Rare Histopathological Finding
por: Alkhaibary, Ali, et al.
Publicado: (2020)

Maximum likelihood estimation of reviewers' acumen in central review setting: categorical data
por: Zhao, Wei, et al.
Publicado: (2011)

Childhood supratentorial ependymomas with YAP1‐MAMLD1 fusion: an entity with characteristic clinical, radiological, cytogenetic and histopathological features
por: Andreiuolo, Felipe, et al.
Publicado: (2018)

Molecular, Pathological, Radiological, and Immune Profiling of Non-brainstem Pediatric High-Grade Glioma from the HERBY Phase II Randomized Trial
por: Mackay, Alan, et al.
Publicado: (2018)

Ependymomas in infancy: underlying genetic alterations, histological features, and clinical outcome
por: Jünger, Stephanie T., et al.
Publicado: (2020)

Expression alterations define unique molecular characteristics of spinal ependymomas
por: Lourdusamy, Anbarasu, et al.
Publicado: (2015)

Clinically aggressive pediatric spinal ependymoma with novel MYC amplification demonstrates molecular and histopathologic similarity to newly described MYCN-amplified spinal ependymomas
por: Shatara, Margaret, et al.
Publicado: (2021)

EPEN-05. Adenosine receptor expression in paediatric ependymoma
por: Spanoudakis, Chelsea, et al.
Publicado: (2022)

EPEN-24. SIOP EPENDYMOMA II: CENTRAL EPENDYMOMA MANAGEMENT ADVISORY GROUP – THE UK EXPERIENCE
por: Macarthur, Donald C, et al.
Publicado: (2020)

Atypical Imaging of Hemorrhagic Lumbosacral Myxopapillary Ependymoma with Histopathological Correlation: A Case Report
por: Albadr, Fahad, et al.
Publicado: (2020)

Phase II study of intravenous etoposide in patients with relapsed ependymoma (CNS 2001 04)
por: Apps, John R, et al.
Publicado: (2022)

Ependymomas
por: Bertero, Luca, et al.
Publicado: (2022)

HGG-09. MicroRNAs expression profile in Meningioma 1 (MN1) gene altered astroblastoma
por: Antonelli, Manila, et al.
Publicado: (2022)

EPEN-03. LONG-TERM FOLLOW-UP OF AIEOP 2ND SERIES OF CHILDREN AND ADOLESCENT WITH PRIMARY INTRACRANIAL (ST:SUPRATENTORIAL; PF: POSTERIOR FOSSA) EPENDYMOMA AND METHYLATION GROUPS RE-ANALYSES
por: Massimino, Maura, et al.
Publicado: (2020)

Improved risk-stratification for posterior fossa ependymoma of childhood considering clinical, histological and genetic features – a retrospective analysis of the HIT ependymoma trial cohort
por: Jünger, Stephanie T., et al.
Publicado: (2019)

Imaging characteristics of supratentorial ependymomas: Study on a large single institutional cohort with histopathological correlation
por: Mangalore, Sandhya, et al.
Publicado: (2015)

CDKN2A deletion in supratentorial ependymoma with RELA alteration indicates a dismal prognosis: a retrospective analysis of the HIT ependymoma trial cohort
por: Jünger, Stephanie T., et al.
Publicado: (2020)

EPEN-27. CDKN2A DELETION IN SUPRATENTORIAL EPENDYMOMA WITH RELA ALTERATION INDICATES A DISMAL PROGNOSIS – A RETROSPECTIVE ANALYSIS OF THE HIT EPENDYMOMA TRIAL COHORT
por: Jünger, Stephanie T, et al.
Publicado: (2020)

Sacrococcygeal myxopapillary ependymoma with anaplastic ependymoma component in an infant
por: Chakraborti, Shrijeet, et al.
Publicado: (2012)

Wormholes in Host Defense: How Helminths Manipulate Host Tissues to Survive and Reproduce
por: Boyett, Deborah, et al.
Publicado: (2014)

Relevance relations for the concept of reproducibility
por: Atmanspacher, H., et al.
Publicado: (2014)

YAP1/TAZ drives ependymoma-like tumour formation in mice
por: Eder, Noreen, et al.
Publicado: (2020)

The Implementation of DNA Methylation Profiling into a Multistep Diagnostic Process in Pediatric Neuropathology: A 2-Year Real-World Experience by the French Neuropathology Network
por: Pages, Melanie, et al.
Publicado: (2021)

Update on the integrated histopathological and genetic classification of medulloblastoma – a practical diagnostic guideline
por: Pietsch, Torsten, et al.
Publicado: (2016)

Transcriptomic analysis in pediatric spinal ependymoma reveals distinct molecular signatures
por: Lourdusamy, Anbarasu, et al.
Publicado: (2017)

Genetic abnormalities detected in ependymomas by comparative genomic hybridisation
por: Carter, M, et al.
Publicado: (2002)

Supratentorial ependymoma in childhood: more than just RELA or YAP
por: Zschernack, Valentina, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_19qpip88v5j0vvqq2hif3cu2b8